Eli Lilly granted temporary restraining order to halt launch of generic Raloxifene
Eli Lilly and Company has issued the following statement after being granted a temporary restraining order to halt the launch of a generic version of Evista (raloxifene HCl tablets) by Teva Pharmaceuticals.